The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services;Juno Therapeutics, Inc.
发明人:
申请号：
EP06733918.4
公开号：
EP1888000B8
申请日:
2006.01.26
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Methods for modulating responsiveness to increased oxygen levels in an at-risk subject identifying an at-risk subject； and before exposing the identified at-risk subject to an increased amount of oxygen, administering to the at-risk subject an anti-inflammatory agent wherein the responsiveness of the at-risk subject to said increased amount of oxygen is modulated as compared to the responsiveness of the at-risk subject to said increased amount of oxygen in the absence of said anti-inflammatory.
